Cargando…
In-depth Site-specific Analysis of N-glycoproteome in Human Cerebrospinal Fluid and Glycosylation Landscape Changes in Alzheimer's Disease
As the body fluid that directly interchanges with the extracellular fluid of the central nervous system (CNS), cerebrospinal fluid (CSF) serves as a rich source for CNS-related disease biomarker discovery. Extensive proteome profiling has been conducted for CSF, but studies aimed at unraveling site-...
Autores principales: | Chen, Zhengwei, Yu, Qinying, Yu, Qing, Johnson, Jillian, Shipman, Richard, Zhong, Xiaofang, Huang, Junfeng, Asthana, Sanjay, Carlsson, Cynthia, Okonkwo, Ozioma, Li, Lingjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724636/ https://www.ncbi.nlm.nih.gov/pubmed/33862227 http://dx.doi.org/10.1016/j.mcpro.2021.100081 |
Ejemplares similares
-
A Strategy for Discovery and Verification of Candidate Biomarkers in Cerebrospinal Fluid of Preclinical Alzheimer’s Disease
por: Zhong, Xiaofang, et al.
Publicado: (2019) -
Glycoproteomics in Cerebrospinal Fluid Reveals Brain-Specific Glycosylation Changes
por: Baerenfaenger, Melissa, et al.
Publicado: (2023) -
Comparative Evaluation of MS-based Metabolomics Software and Its Application to Preclinical Alzheimer’s Disease
por: Hao, Ling, et al.
Publicado: (2018) -
In-depth mapping of the mouse brain N-glycoproteome reveals widespread N-glycosylation of diverse brain proteins
por: Fang, Pan, et al.
Publicado: (2016) -
Targeted glycoproteomic identification of cancer cell glycosylation
por: Powlesland, Alex S, et al.
Publicado: (2009)